EP Patent

EP4382097A1 — A tablet comprising teriflunomide

Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2024-06-12 · 2y expired

What this patent protects

The present invention relates to a film coated tablet comprising teriflunomide, wherein the tablet comprising calcium stearate as lubricant and teriflunomide has a d (0.5) particle between 1 µm and 18 µm. Further the present invention discloses a method for the preparation of sai…

USPTO Abstract

The present invention relates to a film coated tablet comprising teriflunomide, wherein the tablet comprising calcium stearate as lubricant and teriflunomide has a d (0.5) particle between 1 µm and 18 µm. Further the present invention discloses a method for the preparation of said tablet.

Drugs covered by this patent

Patent Metadata

Patent number
EP4382097A1
Jurisdiction
EP
Classification
—
Expires
2024-06-12
Drug substance claim
No
Drug product claim
No
Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.